Categories: News

Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders

Recent Posts

CBIH: Potential Rescheduling to Schedule III Could Reward Decades of Scientific Preparation and Regulatory Discipline

Houston, Texas--(Newsfile Corp. - December 15, 2025) - Dante Picazo, CEO of Cannabis Bioscience International…

2 hours ago

Edison Issues Report on discoverIE Group (DSCV)

London, United Kingdom--(Newsfile Corp. - December 15, 2025) - Edison issues report on discoverIE Group…

2 hours ago

Healthcare IT Market Set to More Than Double by 2030 Growing at 15.24% CAGR, Reports Mordor Intelligence

HYDERABAD, India, December 15, 2025 /PRNewswire/ -- According to Mordor Intelligence, the healthcare IT market …

3 hours ago

Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score

Piramal Pharma Solutions recently achieved a net promoter score (NPS) of 55, far surpassing industry…

3 hours ago

Amphastar Announces FDA Approval for Teriparatide Injection

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)…

3 hours ago

Multi Sciences Elevates Research Access with Global Bioz Badges Roll-out

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 15, 2025 / Bioz, Inc., the leading…

3 hours ago